Transcriptomics and functional genetic polymorphisms as biomarkers of micronutrient function: Focus on selenium as an exemplar

Proceedings of the Nutrition Society

Volumn 70, Issue 3, 2011, Pages 365-373

  Hesketh, John ^a   Méplan, Catherine ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cancer; Gene microarray; Selenium; Selenoproteins; single nucleotide polymorphism

Indexed keywords

EID: 85011457234     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665111000115     Document Type: Article

References (65)

1. Rayman MP (2009) Selenoproteins and human health: insightsfrom epidemiological data. Biochim BiophysActa 1790, 1533–1540.
2. Selhub J, Troen A & Rosenberg IH (2010) B vitamins and the agingbrain. Nutr Rev 68 (Suppl. 2),S112–S118.
3. Vercambre MN, Boutron-Ruault MC, Ritchie K, et al(2009) Long-term association of food andnutrient intakes with cognitive and functional decline: a 13-year follow-upstudy of elderly French women. Br J Nutr 102, 419–427.
4. Giovannucci E & Chan AT (2010) Role of vitamin and mineralsupplementation and aspirin use in cancer survivors. J Clin Oncol 28, 4081–4085.
5. Mason JB, Dickstein A, Jacques PF, et al(2007) A temporal association between folicacid fortification and an increase in colorectal cancer rates may beilluminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 16, 1325–1329.
6. Tighe P, Ward M, McNulty H, et al(2011) A dose-finding trial of the effect oflong-term folic acid intervention: implications for food fortificationpolicy. Am J Clin Nutr 93, 11–18.
7. Omenn GS, Goodman GE, Thornquist MD, et al(1996) Risk factors for lung cancer and forintervention effects in CARET, the Beta-Carotene and Retinol EfficacyTrial. J Natl Cancer Inst 88, 1550–1559.
8. Clark LC, Combs GF Jr, Turnbull BW, et al(1996) Effects of selenium supplementationfor cancer prevention in patients with carcinoma of the skin. A randomizedcontrolled trial. Nutritional Prevention of Cancer StudyGroup. JAMA 276, 1957–1963.
9. Lippman SM, Klein EA, Goodman PJ, et al(2009) Effect of selenium and vitamin E onrisk of prostate cancer and other cancers: the Selenium and Vitamin E CancerPrevention Trial (SELECT). JAMA 301, 39–51.
10. Prasad AS (2009) Impact of the discovery of human zincdeficiency on health. J Am Coll Nutr 28, 257–265. 20150599
11. Tumer Z & Moller LB (2010) Menkes disease. Eur J Hum Genet 18, 511–518.
12. Haggarty P (2007) B-vitamins, genotype and diseasecausality. Proc Nutr Soc 66, 539–547.
13. Bowen PE, Garg V, Stacewicz-Sapuntzakis M, et al(1993) Variability of serum carotenoids inresponse to controlled diets containing six servings of fruits andvegetables per day. Ann N Y Acad Sci 691, 241–243.
14. Leung WC, Hessel S, Meplan C, et al(2009) Two common single nucleotidepolymorphisms in the gene encoding beta-carotene 15,15′-monoxygenasealter beta-carotene metabolism in female volunteers. FASEB J 23, 1041–1053.
15. Meplan C, Crosley LK, Nicol F, et al(2007) Genetic polymorphisms in the humanselenoprotein P gene determine the response of selenoprotein markers toselenium supplementation in a gender-specific manner (the SELGENstudy). FASEB J 21, 3063–3074.
16. Meplan C, Crosley LK, Nicol F, et al(2008) Functional effects of a commonsingle-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4gene: interaction with sex. Am J Clin Nutr 87, 1019–1027.
17. Hesketh J (2008) Nutrigenomics and selenium: geneexpression patterns, physiological targets, and genetics. Annu Rev Nutr 28, 157–177.
18. Bellinger FP, Raman AV, Reeves MA, et al(2009) Regulation and function ofselenoproteins in human disease. Biochem J 422, 11–22.
19. Castets P, Bertrand AT, Beuvin M, et al(2011) Satellite cell loss and impairedmuscle regeneration in selenoprotein N deficiency. Hum Mol Genet 20, 694–704.
20. Dumitrescu AM, Di Cosmo C, Liao XH, et al(2010) The syndrome of inherited partialSBP2 deficiency in humans. Antioxid RedoxSignal 12, 905–920.
21. Schoenmakers E, Agostini M, Mitchell C, et al(2010) Mutations in the selenocysteineinsertion sequence-binding protein 2 gene lead to a multisystemselenoprotein deficiency disorder in humans. J ClinInvest 120, 4220–4235.
22. Foster CB, Aswath K, Chanock SJ, et al(2006) Polymorphism analysis of sixselenoprotein genes: support for a selective sweep at the glutathioneperoxidase 1 locus (3p21) in Asian populations. BMCGenet 7, 56.
23. Forsberg L, de Faire U, Marklund SL, et al(2000) Phenotype determination of a commonPro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells Mol Dis 26, 423–426.
24. Jablonska E, Gromadzinska J, Reszka E, et al(2009) Association between GPx1 Pro198Leupolymorphism, GPx1 activity and plasma selenium concentration inhumans. Eur J Nutr 48, 383–386.
25. Villette S, Kyle JA, Brown KM, et al(2002) A novel single nucleotidepolymorphism in the 3′ untranslated region of human glutathioneperoxidase 4 influences lipoxygenase metabolism. Blood Cells Mol Dis 29, 174–178.
26. Sutherland A, Kim DH, Relton C, et al(2010) Polymorphisms in the selenoprotein Sand 15-kDa selenoprotein genes are associated with altered susceptibility tocolorectal cancer. Genes Nutr 5, 215–223.
27. Bermano G, Pagmantidis V, Holloway N, et al(2007) Evidence that a polymorphism withinthe 3′UTR of glutathione peroxidase 4 is functional and is associatedwith susceptibility to colorectal cancer. GenesNutr 2, 225–232.
28. Burk RF & Hill KE (2009) Selenoprotein P-expression, functions,and roles in mammals. Biochim Biophys Acta 1790, 1441–1447.
29. Mostert V, Lombeck I & Abel J (1998) A novel method for the purification ofselenoprotein P from human plasma. Arch BiochemBiophys 357, 326–330.
30. Al-Taie OH, Seufert J, Mork H, et al(2002) A complex DNA-repeat structure withinthe Selenoprotein P promoter contains a functionally relevant polymorphismand is genetically unstable under conditions of mismatch repairdeficiency. Eur J Hum Genet 10, 499–504.
31. Meplan C, Nicol F, Burtle BT, et al(2009) Relative abundance of selenoprotein Pisoforms in human plasma depends on genotype, se intake, and cancerstatus. Antioxid Redox Signal 11, 2631–2640.
32. Hu YJ, Korotkov KV, Mehta R, et al(2001) Distribution and functionalconsequences of nucleotide polymorphisms in the 3′-untranslated regionof the human Sep15 gene. Cancer Res 61, 2307–2310. 11280803
33. Curran JE, Jowett JB, Elliott KS, et al(2005) Genetic variation in selenoprotein Sinfluences inflammatory response. Nat Genet 37, 1234–1241.
34. Stoedter M, Renko K, Hog A, et al(2010) Selenium controls the sex-specificimmune response and selenoprotein expression during the acute-phase responsein mice. Biochem J 429, 43–51.
35. Zeng J, Du S, Zhou J, et al(2008) Role of SelS inlipopolysaccharide-induced inflammatory response in hepatoma HepG2cells. Arch Biochem Biophys 478, 1–6.
36. Voetsch B, Jin RC, Bierl C, et al(2007) Promoter polymorphisms in the plasmaglutathione peroxidase (GPx-3) gene: a novel risk factor for arterialischemic stroke among young adults and children. Stroke 38, 41–49.
37. Voetsch B, Jin RC, Bierl C, et al(2008) Role of promoter polymorphisms in theplasma glutathione peroxidase (GPx-3) gene as a risk factor for cerebralvenous thrombosis. Stroke 39, 303–307.
38. Cox DG, Tamimi RM & Hunter DJ (2006) Gene×Gene interaction between MnSODand GPX-1 and breast cancer risk: a nested case-controlstudy. BMC Cancer 6, 217.
39. Ichimura Y, Habuchi T, Tsuchiya N, et al(2004) Increased risk of bladder cancerassociated with a glutathione peroxidase 1 codon 198variant. J Urol 172, 728–732.
40. Ravn-Haren G, Olsen A, Tjonneland A, et al(2006) Associations between GPX1 Pro198Leupolymorphism, erythrocyte GPX activity, alcohol consumption and breastcancer risk in a prospective cohort study. Carcinogenesis 27, 820–825.
41. Meplan C, Hughes DJ, Pardini B, et al(2010) Genetic variants in selenoproteingenes increase risk of colorectal cancer. Carcinogenesis 31, 1074–1079.
42. Shibata T, Arisawa T, Tahara T, et al(2009) Selenoprotein S (SEPS1) gene −105G>A promoter polymorphism influences the susceptibility to gastriccancer in the Japanese population. BMCGastroenterol 9, 2.
43. Cooper ML, Adami HO, Gronberg H, et al(2008) Interaction between single nucleotidepolymorphisms in selenoprotein P and mitochondrial superoxide dismutasedetermines prostate cancer risk. Cancer Res 68, 10171–10177.
44. Steinbrecher A, Meplan C, Hesketh J, et al(2010) Effects of selenium status andpolymorphisms in selenoprotein genes on prostate cancer risk in aprospective study of European men. Cancer EpidemiolBiomarkers Prev 19, 2958–2968.
45. Penney KL, Schumacher FR, Li H, et al A large prospective study of SEP15 genetic variation, interactionwith plasma selenium levels, and prostate cancer risk andsurvival. Cancer Prev Res 3, 604–610
46. Bermano G, Nicol F, Dyer JA, et al(1995) Tissue-specific regulation ofselenoenzyme gene expression during selenium deficiency inrats. Biochem J 311 425–430.
47. Sunde RA, Raines AM, Barnes KM, et al(2009) Selenium status highly regulatesselenoprotein mRNA levels for only a subset of the selenoproteins in theselenoproteome. Biosci Rep 29, 329–338.
48. Kipp A, Banning A, vanSchothorst EM, et al(2009) Four selenoproteins, proteinbiosynthesis, and Wnt signalling are particularly sensitive to limitedselenium intake in mouse colon. Mol Nutr FoodRes 53, 1561–1572.
49. Pagmantidis V, Bermano G, Villette S, et al(2005) Effects of Se-depletion onglutathione peroxidase and selenoprotein W gene expression in thecolon. FEBS Lett 579, 792–796.
50. Müller M, Banning A, Brigelius-Flohé R, et al(2010) Nrf2 target genes are induced undermarginal selenium-deficiency. Genes Nutr 5, 297–307.
51. Pagmantidis V, Meplan C, vanSchothorst EM, et al(2008) Supplementation of healthy volunteerswith nutritionally relevant amounts of selenium increases the expression oflymphocyte protein biosynthesis genes. Am J ClinNutr 87, 181–189. 18175754
52. Dong Y, Ganther HE, Stewart C, et al(2002) Identification of molecular targetsassociated with selenium-induced growth inhibition in human breast cellsusing cDNA microarrays. Cancer Res 62, 708–714. 11830524
53. Zhao H, Whitfield ML, Xu T, et al(2004) Diverse effects of methylseleninicacid on the transcriptional program of human prostate cancercells. Mol Biol Cell 15, 506–519.
54. Jacobs ET, Jiang R, Alberts DS, et al(2004) Selenium and colorectal adenoma:results of a pooled analysis. J Natl CancerInst 96, 1669–1675.
55. Russo MW, Murray SC, Wurzelmann JI, et al(1997) Plasma selenium levels and the riskof colorectal adenomas. Nutr Cancer 28, 125–129.
56. Irons R, Carlson BA, Hatfield DL, et al(2006) Both selenoproteins and low molecularweight selenocompounds reduce colon cancer risk in mice with geneticallyimpaired selenoprotein expression. J Nutr 136, 1311–1317. 16614422
57. Malhotra JD & Kaufman RJ (2007) The endoplasmic reticulum and theunfolded protein response. Semin Cell DevBiol 18, 716–731.
58. Zhang K & Kaufman RJ (2008) From endoplasmic-reticulum stress to theinflammatory response. Nature 454, 455–462.
59. Li G, Scull C, Ozcan L, et al(2010) NADPH oxidase links endoplasmicreticulum stress, oxidative stress, and PKR activation to induceapoptosis. J Cell Biol 191, 1113–1125.
60. Kim J, Cha YN, & Surh YJ (2010) A protective role of nuclearfactor-erythroid 2-related factor-2 (Nrf2) in inflammatorydisorders. Mutat Res 690, 12–23.
61. Gao Y, Feng HC, Walder K, et al(2004) Regulation of the selenoprotein SelSby glucose deprivation and endoplasmic reticulum stress – SelS is anovel glucose-regulated protein. FEBS Lett 563, 185–190.
62. Zhang N, Jing W, Cheng J, et al(2010) Molecular characterization andNF-kappaB-regulated transcription of selenoprotein S from the Bamamini-pig. Mol Biol Rep. AMBIGUOUS (296 citations)
63. Du S, Liu H, & Huang K (2010) Influence of SelS gene silence onbeta-Mercaptoethanol-mediated endoplasmic reticulum stress and cellapoptosis in HepG2 cells. Biochim BiophysActa 1800, 511–517.
64. Wingler K, Bocher M, Flohe L, et al(1999) mRNA stability and selenocysteineinsertion sequence efficiency rank gastrointestinal glutathione peroxidasehigh in the hierarchy of selenoproteins. Eur JBiochem 259, 149–157.
65. vanOmmen B, El-Sohemy A, Hesketh J, et al(2010) The Micronutrient Genomics Project: acommunity-driven knowledge base for micronutrient research. Genes Nutr 5, 285–296.